- 501-1000 Employees
- Based in Mechelen, Belgium
Galapagos (Euronext & NASDAQ: GLPG) is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos’ pipeline comprises Phase 3 through to discovery programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications. Their target discovery platform has delivered three novel mechanisms…More
Most Recent Responsibility Report
2021 CSR Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Galapagos NV Sustainability Report, Galapagos NV Corporate Social Responsibility Report, Galapagos NV CSR Report, Galapagos NV Corporate Responsibility, Galapagos NV CR Report, Galapagos NV Citizenship Report, Galapagos NV ESG Report, and Galapagos NV Environmental Report online.